Alectinib in Neo-adjuvant Treatment of Stage III NSCLC

NCT05015010 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Non Small Cell Lung Cancer

Interventions

DRUG: Alectinib

Sponsor

Gruppo Oncologico Italiano di Ricerca Clinica